Visit our Filed page for categories. To browse by specific topic, see our Inside page. For a list of companies covered on this site, visit our Companies page.
Bristol-Myers Squibb Co. and Sanofi-Aventis SA have recalled about 64 million tablets of hypertension drug Avalide because a manufacturing problem could affect the drug’s efficacy.
It is the second significant recall of Avalide in recent months. In September, Bristol and Sanofi recalled about 60 million tablets. Get the full story »
Bristol-Myers Squibb Co. posted a slight decline in third-quarter profit Tuesday as its restrained spending was offset by flat sales of its drugs, lower income from its partners and bigger discounts to government because of the health care overhaul.
Bristol-Myers Squibb Co. says it is recalling eight production lots of its anti-clotting drug Coumadin because the amount of the active ingredient in the drug could change. Get the full story »
Bristol-Myers Squibb has recalled some of its samples of Coumadin, a popular blood thinner, because of a variation in an ingredient that stabilizes the active drug.
A spokeswoman for the company said 8 lots, or 144,700 samples, each of which contained 10 tablets, have been recalled. The affected lots were distributed only as samples, she said. Get the full story »
